Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Gavoille A, Kerbrat A, Edan G, Le Page E, Rollot F, Casey R, Mathey G, Stankoff B, Ciron J, De Seze J, Ruet A, Labauge PM, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, David T, Magy L, Camdessanche JP, Moulin S, Doghri I, Sarov M, Dos Santos A, Pottier C, Manchon E, Aboab J, Tchikviladze M, Dahan C, Durozard P, Scherer-Gagou C, Leclancher A, Laplaud DA, Vukusic S, Michel L, for OFSEP

Open source

DOI
10.1212/wnl.0000000000214943
Published
2026 May 26
Container
Neurology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000214943,
  title = {Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.},
  author = {Gavoille A and Kerbrat A and Edan G and Le Page E and Rollot F and Casey R and Mathey G and Stankoff B and Ciron J and De Seze J and Ruet A and Labauge PM and Kwiatkowski A and Zephir H and Papeix C and Defer G and Lebrun-Frenay C and Moreau T and Berger E and Clavelou P and Thouvenot E and Heinzlef O and Pelletier J and Al Khedr A and Casez O and Bourre B and Wahab A and David T and Magy L and Camdessanche JP and Moulin S and Doghri I and Sarov M and Dos Santos A and Pottier C and Manchon E and Aboab J and Tchikviladze M and Dahan C and Durozard P and Scherer-Gagou C and Leclancher A and Laplaud DA and Vukusic S and Michel L and for OFSEP},
  year = {2026},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000214943},
  url = {https://doi.org/10.1212/wnl.0000000000214943}
}

RIS

TY  - JOUR
TI  - Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
AU  - Gavoille A
AU  - Kerbrat A
AU  - Edan G
AU  - Le Page E
AU  - Rollot F
AU  - Casey R
AU  - Mathey G
AU  - Stankoff B
AU  - Ciron J
AU  - De Seze J
AU  - Ruet A
AU  - Labauge PM
AU  - Kwiatkowski A
AU  - Zephir H
AU  - Papeix C
AU  - Defer G
AU  - Lebrun-Frenay C
AU  - Moreau T
AU  - Berger E
AU  - Clavelou P
AU  - Thouvenot E
AU  - Heinzlef O
AU  - Pelletier J
AU  - Al Khedr A
AU  - Casez O
AU  - Bourre B
AU  - Wahab A
AU  - David T
AU  - Magy L
AU  - Camdessanche JP
AU  - Moulin S
AU  - Doghri I
AU  - Sarov M
AU  - Dos Santos A
AU  - Pottier C
AU  - Manchon E
AU  - Aboab J
AU  - Tchikviladze M
AU  - Dahan C
AU  - Durozard P
AU  - Scherer-Gagou C
AU  - Leclancher A
AU  - Laplaud DA
AU  - Vukusic S
AU  - Michel L
AU  - for OFSEP
PY  - 2026
JO  - Neurology
DO  - 10.1212/wnl.0000000000214943
UR  - https://doi.org/10.1212/wnl.0000000000214943
ER  -

APA

A, G., A, K., G, E., E, L. P., F, R., R, C., G, M., B, S., J, C., J, D. S., A, R., PM, L., A, K., H, Z., C, P., G, D., C, L., T, M., E, B., P, C., E, T., O, H., J, P., A, A. K., O, C., B, B., A, W., T, D., L, M., JP, C., S, M., I, D., M, S., A, D. S., C, P., E, M., J, A., M, T., C, D., P, D., C, S., A, L., DA, L., S, V., L, M., & OFSEP, F. (2026). Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.. Neurology. https://doi.org/10.1212/wnl.0000000000214943

Source records